Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R S Daum

Showing results (41-50 of 108) with videos related to

Pageof 11
Sort By:
Archives of Neurology|October 1, 1982
Ischemic cerebrovascular complications of Haemophilus influenzae meningitis. The value of computed tomographyD W Dunn, R S Daum, L Weisberg, et al.
The Journal of Pediatrics|April 17, 1998
Acute eosinophilic pneumonia: a cause of reversible, severe, noninfectious respiratory failureH Alp, R S Daum, C Abrahams, et al.
The Journal of Infectious Diseases|November 1, 1992
Characterization of Staphylococcus aureus isolates with decreased susceptibility to vancomycin and teicoplanin: isolation and purification of a constitutively produced protein associated with decreased susceptibilityR S Daum, S Gupta, R Sabbagh, et al.
The Journal of Infectious Diseases|March 1, 1988
Epidemiology of rob beta-lactamase among ampicillin-resistant Haemophilus influenzae isolates in the United StatesR S Daum, M Murphey-Corb, E Shapira, et al.
The Journal of Pediatrics|August 1, 1986
Pathogenicity of a rifampin-resistant cerebrospinal fluid isolate of Haemophilus influenzae type bJ McCarty, M P Glodé, D M Granoff, et al.
Infectious Disease Clinics of North America|January 9, 1998
Antimicrobial resistance in staphylococci. Epidemiology, molecular mechanisms, and clinical relevanceM C Maranan, B Moreira, S Boyle-Vavra, et al.
The Journal of Pediatrics|November 1, 1984
Guidelines for dealing with the guidelines: rifampin prophylaxis for day care contacts of patients with serious Haemophilus influenzae type b infectionsR S Daum, J Gilsdorf, D Granoff, et al.
Antimicrobial Agents and Chemotherapy|November 18, 2000
Structural and topological differences between a glycopeptide-intermediate clinical strain and glycopeptide-susceptible strains of Staphylococcus aureus revealed by atomic force microscopyS Boyle-Vavra, J Hahm, S J Sibener, et al.
Infection and Immunity|February 1, 1983
Efficacy of human hyperimmune globulin in prevention of Haemophilus influenzae type b disease in infant ratsD Ambrosino, J R Schreiber, R S Daum, et al.
Antimicrobial Agents and Chemotherapy|August 1, 1997
Increased production of penicillin-binding protein 2, increased detection of other penicillin-binding proteins, and decreased coagulase activity associated with glycopeptide resistance in Staphylococcus aureusB Moreira, S Boyle-Vavra, B L deJonge, et al.
Pageof 11

Showing results (41-50 of 108) with videos related to

Sort By:
Pageof 11
Archives of Neurology|October 1, 1982
Ischemic cerebrovascular complications of Haemophilus influenzae meningitis. The value of computed tomographyD W Dunn, R S Daum, L Weisberg, et al.
The Journal of Pediatrics|April 17, 1998
Acute eosinophilic pneumonia: a cause of reversible, severe, noninfectious respiratory failureH Alp, R S Daum, C Abrahams, et al.
The Journal of Infectious Diseases|November 1, 1992
Characterization of Staphylococcus aureus isolates with decreased susceptibility to vancomycin and teicoplanin: isolation and purification of a constitutively produced protein associated with decreased susceptibilityR S Daum, S Gupta, R Sabbagh, et al.
The Journal of Infectious Diseases|March 1, 1988
Epidemiology of rob beta-lactamase among ampicillin-resistant Haemophilus influenzae isolates in the United StatesR S Daum, M Murphey-Corb, E Shapira, et al.
The Journal of Pediatrics|August 1, 1986
Pathogenicity of a rifampin-resistant cerebrospinal fluid isolate of Haemophilus influenzae type bJ McCarty, M P Glodé, D M Granoff, et al.
Infectious Disease Clinics of North America|January 9, 1998
Antimicrobial resistance in staphylococci. Epidemiology, molecular mechanisms, and clinical relevanceM C Maranan, B Moreira, S Boyle-Vavra, et al.
The Journal of Pediatrics|November 1, 1984
Guidelines for dealing with the guidelines: rifampin prophylaxis for day care contacts of patients with serious Haemophilus influenzae type b infectionsR S Daum, J Gilsdorf, D Granoff, et al.
Antimicrobial Agents and Chemotherapy|November 18, 2000
Structural and topological differences between a glycopeptide-intermediate clinical strain and glycopeptide-susceptible strains of Staphylococcus aureus revealed by atomic force microscopyS Boyle-Vavra, J Hahm, S J Sibener, et al.
Infection and Immunity|February 1, 1983
Efficacy of human hyperimmune globulin in prevention of Haemophilus influenzae type b disease in infant ratsD Ambrosino, J R Schreiber, R S Daum, et al.
Antimicrobial Agents and Chemotherapy|August 1, 1997
Increased production of penicillin-binding protein 2, increased detection of other penicillin-binding proteins, and decreased coagulase activity associated with glycopeptide resistance in Staphylococcus aureusB Moreira, S Boyle-Vavra, B L deJonge, et al.
Pageof 11